Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 4223-4237

  Mane, Viraj ^a   Muro, Silvia ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Antibody; Endocytosis; Gastrointestinal tract; ICAM 1 targeting; Polymer nanocarriers

Indexed keywords

BICARBONATE; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; NANOCARRIER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RETENTION; ENDOCYTOSIS; EPITHELIUM CELL; GASTROINTESTINAL TRACT; ISOTOPE TRACING; MOUSE; MUCOADHESION; NONHUMAN; PERISTALSIS; POLYMERIZATION; ROENTGEN SPECTROSCOPY; STOMACH EPITHELIUM; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; ANIMALS; DRUG CARRIERS; ENDOCYTOSIS; GASTROINTESTINAL TRACT; HISTOCYTOCHEMISTRY; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PROTEIN STABILITY; RATS; TISSUE DISTRIBUTION;

MUS;

EID: 84866737892     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34105     Document Type: Article

References (62)

1. Park K, Kwon IC, Park K. Oral protein delivery: current status and future prospect. React Funct Polym. 2011;71(3):280-287.
2. Mrsny RJ. Modification of epithelial tight junction integrity to enhance transmucosal absorption. Crit Rev Ther Drug Carrier Syst. 2005;22(4):331-418.
3. Tuma PL, Hubbard AL. Transcytosis: crossing cellular barriers. Physiol Rev. 2003;83(3):871-932.
4. Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery-a review. Pharm Sci Technolo Today. 2000;3(4): 138-145.
5. Bender BG, Sazonov V, Krobot KJ. Impact of medication delivery method on patient adherence. In: Harver A, Kotses H, editors. Asthma, Health and Society. New York: Springer US; 2010:107-115.
6. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2): 158-171.
7. Plapied L, Duhem N, Des Rieux A, Préat V. Fate of polymeric nanocarriers for oral drug delivery. Curr Opin Colloid Interface Sci. 2011;16(3): 228-237.
8. Serra L, Doménech J, Peppas NA. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm. 2009;71(3):519-528.
9. Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009; 61(2):75-85.
10. van Hoogevest P, Liu X, Fahr A. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective. Expert Opin Drug Deliv. 2011;8(11):1481-1500.
11. Vinogradov SV, Bronich TK, Kabanov AV. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev. 2002;54(1):135-147.
12. Yoncheva K, Lizarraga E, Irache JM. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci. 2005;24(5): 411-419.
13. Montisci MJ, Dembri A, Giovannuci G, Chacun H, Duchêne D, Ponchel G. Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats. Pharm Res. 2001;18(6): 829-837.
14. Irache JM, Salman HH, Gamazo C, Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv. 2008;5(6):703-724.
15. Bies C, Lehr CM, Woodley JF. Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev. 2004;56(4):425-435.
16. Francis MF, Cristea M, Winnik FM. Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles. Biomacromolecules. 2005;6(5):2462-2467.
17. Salman HH, Gamazo C, Agueros M, Irache JM. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles. Vaccine. 2007;25(48):8123-8132.
18. Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release. 2003;89(2):151-165.
19. Prego C, Torres D, Alonso MJ. The potential of chitosan for the oral administration of peptides. Expert Opin Drug Deliv. 2005;2(5): 843-854.
20. Smith JM, Dornish M, Wood EJ. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. Biomaterials. 2005;26(16):3269-3276.
21. Peppas NA, Wood KM, Blanchette JO. Hydrogels for oral delivery of therapeutic proteins. Expert Opin Biol Ther. 2004;4(6):881-887.
22. Alhaique F, Santucci E, Carafa M, Coviello T, Murtas E, Riccieri FM. Gellan in sustained release formulations: preparation of gel capsules and release studies. Biomaterials. 1996;17(20):1981-1986.
23. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Release. 2006;114(1):1-14.
24. Peppas NA, Kavimandan NJ. Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles. Eur J Pharm Sci. 2006;29(3-4): 183-197.
25. Mundargi RC, Rangaswamy V, Aminabhavi TM. pH-Sensitive oral insulin delivery systems using Eudragit microspheres. Drug Dev Ind Pharm. 2011;37(8):977-985.
26. Lai SK, O'Hanlon DE, Harrold S, etal. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A. 2007;104(5):1482-1487.
27. Dawson M, Krauland E, Wirtz D, Hanes J. Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnol Prog. 2004;20(3): 851-857.
28. Mura S, Hillaireau H, Nicolas J, etal. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules. 2011; 12(11):4136-4143.
29. Takatsuka S, Kitazawa T, Morita T, Horikiri Y, Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur J Pharm Biopharm. 2006;62(1):52-58.
30. El-Sayed M, Ginski M, Rhodes C, Ghandehari H. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release. 2002;81(3):355-365.
31. Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm. 2009;71(3):431-444.
32. Discher DE, Eisenberg A. Polymer vesicles. Science. 2002;297(5583): 967-973.
33. des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1-27.
34. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986; 137(4):1270-1274.
35. Parkos CA, Colgan SP, Diamond MS, etal. Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils. Mol Med. 1996;2(4):489-505.
36. Huang GT, Eckmann L, Savidge TC, Kagnoff MF. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion. J Clin Invest. 1996;98(2):572-583.
37. Burns RC, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Cominelli F, Ley K. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology. 2001;121(6):1428-1436.
38. Watanabe T, Arakawa T, Tominaga K, Fujiwara Y, Higuchi K, Kuroki T. Neutrophil accumulation in development gastric ulcer induced by submucosal injection of endothelin-1in rats. Dig Dis Sci. 2000;45(5):880-888.
39. Maruo Y, Gochi A, Kaihara A, etal. ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer. 2002;100(4):486-490.
40. Danilov SM, Gavrilyuk VD, Franke FE, etal. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol. 2001;280(6):L1335-L1347.
41. Chittasupho C, Xie SX, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur J Pharm Sci. 2009;37(2):141-150.
42. Weller GE, Villanueva FS, Klibanov AL, Wagner WR. Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng. 2002;30(8):1012-1019.
43. Hsu J, Serrano D, Bhowmick T, etal. Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. J Control Release. 2011;149(3):323-331.
44. Sakhalkar HS, Dalal MK, Salem AK, etal. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci U S A. 2003; 100(26):15895-15900.
45. Calderon AJ, Bhowmick T, Leferovich J, etal. Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J Control Release. 2011; 150(1):37-44.
46. Muro S, Garnacho C, Champion JA, etal. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther. 2008;16(8):1450-1458.
47. Muro S, Wiewrodt R, Thomas A, etal. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci. 2003;116(Pt 8):1599-1609.
48. Fu TJ, Abbott UR, Hatzos C. Digestibility of food allergens and nonallergenic proteins in simulated gastric fluid and simulated intestinal fluid-a comparative study. J Agric Food Chem. 2002;50(24): 7154-7160.
49. Saltzman WM, Radomsky ML, Whaley KJ, Cone RA. Antibody diffusion in human cervical mucus. Biophys J. 1994;66(2 Pt 1): 508-515.
50. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J. 2001;81(4):1930-1937.
51. Muro S, Dziubla T, Qiu W, etal. Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther. 2006;317(3):1161-1169.
52. El-Sayed M, Rhodes CA, Ginski M, Ghandehari H. Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm. 2003;265(1-2):151-157.
53. Norris DA, Sinko PJ. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polym Sci. 1997;63(11):1481-1492.
54. Jani P, Halbert GW, Langridge J, Florence AT. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol. 1989;41(12):809-812.
55. An YJ, Lee H, Chang D, etal. Application of pulsed Doppler ultrasound for the evaluation of small intestinal motility in dogs. J Vet Sci. 2001;2(1):71-74.
56. Kinnunen J, Tötterman S, Kaila R, Pietilä J, Linden H, Tervahartiala P. Effect of sodium bicarbonate pretreatment on barium coating of mucosa during double contrast barium meal. Rofo. 1983;139(2):199-201.
57. Lehr CM, Bouwstra JA, Kok W, Noach AB, de Boer AG, Junginger HE. Bioadhesion by means of specific binding of tomato lectin. Pharm Res. 1992;9(4):547-553.
58. Frey A, Giannasca KT, Weltzin R, etal. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med. 1996;184(3):1045-1059.
59. Jun CD, Carman CV, Redick SD, Shimaoka M, Erickson HP, Springer TA. Ultrastructure and function of dimeric, soluble intercellular adhesion molecule-1 (ICAM-1). J Biol Chem. 2001;276(31):29019-29027.
60. Guarino A, Canani RB, Russo S, etal. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics. 1994;93(1): 12-16.
61. Ghaffarian R, Bhowmick T, Muro S. Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. J Control Release. June 12, 2012. [Epub ahead of print.]
62. Langer R, Cleland JL, Hanes J. New advances in microsphere-based single-dose vaccines. Adv Drug Deliv Rev. 1997;28(1):97-119.